martes, 31 de marzo de 2020

Could real-world evidence help shape the future of drug development?

Could real-world evidence help shape the future of drug development?

Cancer Briefing

STAT Plus: Could real-world evidence help shape the future of drug development?

By REBECCA ROBBINS AND ADAM FEUERSTEIN AND DAMIAN GARDE


AETION
STAT speaks with Carolyn Magill, the CEO of Aetion and one of the best-known executives in the space known as real-world evidence.

No hay comentarios:

Publicar un comentario